Nano-Medicine: Revolutionizing Therapeutics, Diagnostics, and Regeneration

Dear Colleagues,

Nanotechnology has emerged as a game-changer in medicine, offering inventive solutions across therapeutics, diagnostics, and tissue regeneration. This field involves manipulating materials at the nanoscale, granting precise control over their characteristics and behavior.

In therapeutics, nanotechnology has transformed drug delivery. Nanoparticles can encase therapeutic agents and be tailored to target specific cells or tissues, boosting drug effectiveness while minimizing side effects. They also serve as carriers for controlled drug release, bolstering drug stability and availability.

Nanoparticles can be modified with specific elements to detect disease biomarkers, enhancing imaging techniques like MRI, CT scans, and fluorescence imaging. Nanotech-based diagnostics offer better sensitivity and early disease detection potential.

Additionally, nanotechnology aids tissue regeneration by providing scaffolds and hydrogels that support cell growth and mimic natural tissues. These materials promote cell adhesion and growth, with controlled release of growth factors aiding tissue repair.

By merging nanotechnology and medicine, we're exploring new avenues for targeted therapies, early detection, and improved tissue regeneration. This special issue showcases various studies and reviews highlighting nanotechnology's diverse applications in medicine, spanning therapeutics, diagnostics, and tissue regeneration.

Dr. Sonali Suresh Rohiwal
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• drug delivery systems
• targeted therapies
• disease detection
• tissue regeneration
• regenerative medicine
• nanomaterials